Compare

GeneDx Holdings Corp. vs Omada Health, Inc. vs Pennant Group, Inc. vs InnovAge Holding Corp.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearGeneDx Holdings Corp.
WGS
Omada Health, Inc.
OMDA
Pennant Group, Inc.
PNTG
InnovAge Holding Corp.
INNV
Year ended2025-12-312025-12-312025-12-312026-06-30
Revenue$427.54M$260.21M$947.71M$989.71M
Revenue growth (YoY)+40.0%+53.2%+36.3%+15.9%
Gross margin69.7%65.7%n/a23.0%
Operating margin-3.1%-4.6%5.5%0.3%
Net margin-4.9%-4.9%3.1%-0.3%
Net income-$21.02M-$12.78M$29.58M-$2.54M
EPS (Diluted)-$0.73-$0.35$0.84-$0.02
Operating cash flow$33.28M$18.25M$48.29M$64.71M
Free cash flow$14.26M$16.93M$36.26M$50.41M
Cash & equivalents$105.00M$222.04Mn/a$97.89M
Total assets$523.71M$305.41M$968.18M$557.39M
Total liabilities$215.53M$75.73M$593.93M$288.62M
Shareholders' equity$308.18M$229.68M$374.25M$235.60M
Return on year-end equity-6.8%-5.6%7.9%-1.1%
Shares outstanding29.25M58.43M34.63M136.02M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearGeneDx Holdings Corp.Omada Health, Inc.Pennant Group, Inc.InnovAge Holding Corp.
Latest$427.54M
Ended 2025-12-31
$260.21M
Ended 2025-12-31
$947.71M
Ended 2025-12-31
$989.71M
Ended 2026-06-30
1 year earlier$305.45M
Ended 2024-12-31
$169.80M
Ended 2024-12-31
$695.24M
Ended 2024-12-31
$853.70M
Ended 2025-06-30
2 years earlier$202.57M
Ended 2023-12-31
$122.78M
Ended 2023-12-31
$544.89M
Ended 2023-12-31
$763.86M
Ended 2024-06-30
3 years earlier$234.69M
Ended 2022-12-31
n/a$473.24M
Ended 2022-12-31
$688.09M
Ended 2023-06-30
4 years earlier$212.19M
Ended 2021-12-31
n/a$439.69M
Ended 2021-12-31
$698.64M
Ended 2022-06-30